Expand AKTX Menu
AKTX MENU

Akari Therapeutics PLC - American Depositary Shares (AKTX) closed at $6.80 on November 13, 2026, up 4.5% from the previous close, on volume of 21,280 shares (30-day average 42,519).

Key numbers
  • Last close: $6.80 (November 13, 2026)
  • 52-week range: $3.02 to $29.32
  • Market value: $15.5 million

Data as of November 13, 2026.

AKTX Stock Summary and Trading Ideas (Akari Therapeutics PLC - American Depositary Shares | NASDAQ:AKTX)

Charts for Today's Stock Price and Implied Volatility in Akari Therapeutics PLC - American Depositary Shares

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AKTX by Theoretical Edge and Win Rates

Sentiment

News

Akari Therapeutics reports Q3 results

Seeking Alpha News (Fri, 13-Nov 2:13 PM ET)

Trading Statistics

Key Ratios

Akari Therapeutics PLC - American Depositary Shares (AKTX) Frequently Asked Questions

What does Akari Therapeutics PLC - American Depositary Shares do?

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) built around novel, proprietary payloads utilizing powerful biology to attack cancer. Its payload, PH1, targets RNA splicing by modulating the spliceosome, a complex machinery in the cell that converts pre-RNA into spliced RNA for translation into vital proteins for cell survival and growth. Its product pipeline is AKTX-101, which targets the Trop2 receptor on cancer cells and, with a proprietary linker, enables it to deliver its novel PH1 payload directly into the tumor with minimal off-target effects. and AKTX-102, an ADC candidate targeting CEACAM5 (Carcinoembryonic Antigen-related Cell Adhesion Molecule-5), a well-validated tumor antigen expressed across multiple solid tumors.

What symbol and exchange does Akari Therapeutics PLC - American Depositary Shares shares trade?

Akari Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AKTX.

What is Akari Therapeutics PLC - American Depositary Shares stock price doing today?

As of November 16, 2026, AKTX stock price declined to $6.53 with 11,476 million shares trading.

What is Akari Therapeutics PLC - American Depositary Shares's Beta?

AKTX has a beta of 3.27, meaning it tends to be more sensitive to market movements. AKTX has a correlation of 0.04 to the broad based SPY ETF.

How much is Akari Therapeutics PLC - American Depositary Shares worth?

AKTX has a market cap of $14.92 million. This is considered a Sub-Micro Cap stock.

What is the highest and lowest price Akari Therapeutics PLC - American Depositary Shares traded in the last 3 year period?

In the last 3 years, AKTX traded as high as $176.00 and as low as $3.02.

Is Akari Therapeutics PLC - American Depositary Shares (AKTX) a good investment?

AKTX has underperformed the market in the last year with a price return of -68.6% while the SPY ETF gained +11.7%. AKTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -6.7% and -20.8%, respectively, while the SPY returned -4.2% and -1.7%, respectively.

What are the support and resistance levels for Akari Therapeutics PLC - American Depositary Shares (AKTX)?

AKTX support price is $6.08 and resistance is $7.52 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKTX shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes